A5050535156- Aortic aneurysm repair treatments
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Infectious Aortic and Vascular Conditions
- Cerebrovascular and Carotid Artery Diseases
- Acute Ischemic Stroke Management
- Cardiac, Anesthesia and Surgical Outcomes
- Inflammatory Biomarkers in Disease Prognosis
- Renal and Vascular Pathologies
- Foreign Body Medical Cases
- Esophageal and GI Pathology
- Cerebrovascular and genetic disorders
- Advanced X-ray and CT Imaging
- Abdominal vascular conditions and treatments
- Aortic Disease and Treatment Approaches
- Cardiovascular Disease and Adiposity
- Quantum Chromodynamics and Particle Interactions
- COVID-19 and healthcare impacts
- Neuroendocrine Tumor Research Advances
- Pleural and Pulmonary Diseases
- Data Quality and Management
- Occupational and environmental lung diseases
- Central Venous Catheters and Hemodialysis
- Intracranial Aneurysms: Treatment and Complications
- Atherosclerosis and Cardiovascular Diseases
University of Verona
2015-2024
Fondazione Ricerca Molinette
1991
This observational, retrospective study aims establishing the role of red blood cell distribution width (RDW) for identifying abdominal aortic aneurism (AAA) patients at risk developing post-implantation syndrome (PiS) after endovascular aneurysm repair (EVAR).The population consisted all undergoing EVAR AAA University Hospital Verona (Italy), between June 1, 2016 and May 31, 2018. Blood samples measuring hemoglobin, mean corpuscular volume (MCV) RDW were collected hospital admission day...
The identification of patients at higher risk developing percutaneous transluminal angioplasty (PTA)-related complications is pivotal for achieving better clinical outcomes. We carried out a single-center, observational, retrospective study to explore whether in-hospital changes red blood cell distribution width (RDW) may help predicting early development PTA-related complications. population consisted all consecutive who underwent PTA severe peripheral artery occlusive disease (PAOD) during...
Introduction: This article aims to evaluate the short-term and mid-term performance of a self-expanding covered stent (COVERA Plus, Bard Tempe, Arizona) during treatment Trans-Atlantic Inter-Society Consensus (TASC) C/D aortoiliac obstructive lesions involving aortic bifurcation. Methods: A single-center retrospective review all patients who underwent endovascular reconstruction bifurcation for disease, with use Covera, from January 2018 March 2023. All received postoperative CTA (computed...
The aim of the study was to evaluate outcome first line hybrid treatment in patients with chronic limb threatening ischemia (CLTI) and possible predictors primary patency (PP) loss clinical improvement (LCI).This a retrospective non-randomized study. All underwent one-stage common femoral artery (CFA) endarterectomy combined an inflow and/or outflow endovascular revascularization procedure. Demographic, clinical, lesion characteristics for each patient were reported. Primary analysis...
A 78-year-old woman presented with type IIIC and IIID endoleaks after endovascular treatment for a thoracoabdominal aortic aneurysm. Mating between the ruptured segments of superior mesenteric artery stent graft was performed. After failed attempts at relining right renal graft, hybrid approach used to connect side branch target vessel: deployed into main it temporarily occluded balloon. opening sac, two grafts were connected running suture. Follow-up examination performed 1 month...
The purpose of this study was to evaluate the usefulness tumor-associated trypsin inhibitor (TATI) determination in serum and pleural fluid for differential diagnosis relapsing effusions. concentrations TATI were determined samples from 51 patients with effusions comprising 20 benign exudates, 5 transudates 26 malignant levels overlapped fluids. This precludes use marker For CEA seems be best tumor a sensitivity frequently higher than that cytology.